Abstract
Alzheimer type of dementia is accompanied with progressive loss of cognitive function that directly correlates with accumulation of amyloid beta plaques. It is known that Fibroblast growth factor 21 (FGF21), a metabolic hormone, with strong neuroprotective potential, is induced during oxidative stress in Alzheimer’s disease. Interestingly, FGF21 cross-talks with autophagy, a mechanism involved in the clearance of abnormal protein aggregate. Moreover, autophagy activation by Rapamycin delivers neuroprotective role in Alzheimer’s disease. However, the synergistic neuroprotective efficacy of overexpressed FGF21 along with Rapamycin is not yet investigated. Therefore, the present study examined whether overexpressed FGF21 along with autophagy activation ameliorated neurodegenerative pathology in Alzheimer’s disease. We found that cognitive deficits in rats with intracerebroventricular injection of Amyloid beta1-42 oligomers were restored when injected with FGF21-expressing lentiviral vector combined with Rapamycin. Furthermore, overexpression of FGF21 along with Rapamycin downregulated protein levels of Amyloid beta1-42 and phosphorylated tau and expression of major autophagy proteins along with stabilization of oxidative stress. Moreover, FGF21 overexpressed rats treated with Rapamycin revamped the neuronal density as confirmed by histochemical, cresyl violet and immunofluorescence analysis. These results generate compelling evidence that Alzheimer’s disease pathology exacerbated by oligomeric amyloid beta may be restored by FGF21 supplementation combined with Rapamycin and thus present an appropriate treatment paradigm for people affected with Alzheimer’s disease.
Graphical abstract
Similar content being viewed by others
Data Availability
All data generated or analysed during this study are included in the manuscript.
Code Availability
Not applicable.
Abbreviations
- AD:
-
:Alzheimer’s disease
- APPβ:
-
:Amyloid precursor proteinbeta
- ATF4:
-
:Activating transcription factor 4
- Aβ:
-
:Amyloid beta
- BACE1:
-
:Beta-site APP cleaving enzyme 1
- BSA:
-
:Bovine serum albumin
- CA1:
-
:Cornu ammonis-1
- CA2:
-
:Cornu ammonis-2
- CA3:
-
:Cornu ammonis-3
- CV:
-
:Cresyl violet
- DAPI:
-
:4′,6-diamidino-2-phenylindole
- DG:
-
:Dentate gyrus
- DMEM:
-
:Dulbecco’s modified essential medium
- EMEM:
-
:Eagles modified essential medium
- FBS:
-
:Foetal bovine serum
- FESEM:
-
:Field emission scanning electron microscopy
- FGF21:
-
:Fibroblast growth factor 21
- GFAP:
-
:Glial fibrillary acidic protein
- GFP:
-
:Green fluorescent protein
- GSH:
-
:Reduced Glutathione
- H&E:
-
:Haematoxylin & eosin
- HFIP:
-
:Hexafluoroisopropanol
- IBA-1:
-
:Ionized calcium binding adaptor molecule 1
- ICV:
-
:Intra-cerebroventricular
- IR:
-
:Insulin resistance
- LAMP-2:
-
:Lysosomal associated membrane protein-2
- LC3:
-
:Microtubule-associated protein 1A/1B-light chain 3
- LV:
-
:Lentiviral vector
- MDA:
-
:Malondialdehyde
- mtDNA:
-
:Mitochondrial deoxyribonucleic
- mTORC1:
-
:Mechanistic target of rapamycin complex 1
- MWM:
-
:Morris water maze
- NC:
-
:Normal control
- NFTs:
-
:Neurofibrillary tangles
- PBS:
-
:Phosphate buffer saline
- PEG:
-
:Poly (ethylene glycol) methyl ether
- PFA:
-
:Paraformaldehyde
- ptau:
-
:phosphorylated tau
- qRT-PCR:
-
:Real-time quantitative polymerase chain reaction
- RAM:
-
:Radial arm maze
- RAM:
-
:Radial arm maze
- Rapa:
-
:Rapamycin
- RNA:
-
:Ribonucleic acid
- sAPPβ:
-
:Soluble amyloid precursor proteinbeta
- SOD:
-
:Superoxide Dismutase
- UPRmt:
-
:Mitochondrial unfolded protein response
- VP:
-
:Vector plasmid
References
Jahn H (2013) Memory loss in Alzheimer’s disease. Dialogues Clin Neurosci 15:445
M Ashraf G, H Greig N, A Khan T, et al (2014) Protein misfolding and aggregation in Alzheimer’s disease and type 2 diabetes mellitus. CNS Neurol Disord Targets (Formerly Curr Drug Targets-CNS Neurol Disord 13:1280–1293
Sarathlal KC, Kakoty V, Marathe S, et al (2020) Exploring the neuroprotective potential of rosiglitazone embedded nanocarrier system on streptozotocin induced mice model of Alzheimer’s disease. Neurotox Res 1–16
Kakoty V, Sarathlal KC, Tang R-D, et al (2020) Fibroblast growth factor 21 and autophagy: a complex interplay in Parkinson disease. Biomed Pharmacother 127:110145
Kim SH, Kim KH, Kim H-K et al (2015) Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. Diabetologia 58:809–818
Naresh NU, Haynes CM (2019) Signaling and regulation of the mitochondrial unfolded protein response. Cold Spring Harb Perspect Biol 11:a033944
Kim KH, Jeong YT, Oh H et al (2013) Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat Med 19:83
Shao L-W, Niu R, Liu Y (2016) Neuropeptide signals cell non-autonomous mitochondrial unfolded protein response. Cell Res 26:1182–1196
Khan NA, Nikkanen J, Yatsuga S et al (2017) mTORC1 regulates mitochondrial integrated stress response and mitochondrial myopathy progression. Cell Metab 26:419–428
Magnuson B, Ekim B, Fingar DC (2012) Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 441:1–21
Hsuchou H, Pan W, Kastin AJ (2007) The fasting polypeptide FGF21 can enter brain from blood. Peptides 28:2382–2386
Minard AY, Tan S-X, Yang P et al (2016) mTORC1 is a major regulatory node in the FGF21 signaling network in adipocytes. Cell Rep 17:29–36
Schreiber KH, Apelo SIA, Yu D et al (2019) A novel rapamycin analog is highly selective for mTORC1 in vivo. Nat Commun 10:1–12
FDA (2017) Wyeth-Ayerst Pharmaceuticals. RAPAMUNE (sirolimus) [package insert]. US Food Drug Adm website Revised July 2011.
Reid J (2018) Novel insights into protein synthesis rates in the brain following two lifespan-extending treatments. Colorado State University
Van Skike CE, Jahrling JB, Olson AB, et al (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer’s disease and vascular cognitive impairment. Am J Physiol Circ Physiol
Caccamo A, De Pinto V, Messina A et al (2014) Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer’s disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature. J Neurosci 34:7988–7998
Jiang T, Yu J-T, Zhu X-C et al (2014) Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer’s disease. Pharmacol Res 81:54–63
Krishna KV, Saha RN, Dubey SK (2020) Biophysical, biochemical, and behavioral implications of ApoE3 conjugated donepezil nanomedicine in a Aβ1–42 induced Alzheimer’s disease Rat Model. ACS Chem Neurosci 11:4139–4151
Sharma S, Taliyan R (2015) Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats. Naunyn Schmiedebergs Arch Pharmacol 388:337–349
Lu Z, Liu F, Chen L, et al (2015) Effect of chronic administration of low dose rapamycin on development and immunity in young rats. PLoS One 10:e0135256
Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47–60
Sharma S, Taliyan R (2014) Neuroprotective role of Indirubin-3′-monoxime, a GSKβ inhibitor in high fat diet induced cognitive impairment in mice. Biochem Biophys Res Commun 452:1009–1015
Sharma S, Taliyan R, Ramagiri S (2015) Histone deacetylase inhibitor, trichostatin A, improves learning and memory in high-fat diet-induced cognitive deficits in mice. J Mol Neurosci 56:1–11
Sharma S, Taliyan R, Singh S (2015) Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: modulation of histone deacetylase activity. Behav Brain Res 291:306–314
Moorthi P, Premkumar P, Priyanka R et al (2015) Pathological changes in hippocampal neuronal circuits underlie age-associated neurodegeneration and memory loss: positive clue toward SAD. Neuroscience 301:90–105
Classics Lowry O, Rosebrough N, Farr A, Randall R (1951) Protein measurement with the Folin phenol reagent. J biol Chem 193:265–275
Kakoty V, KC S, Dubey SK, et al (2021) Neuroprotective effects of trehalose and sodium butyrate on preformed fibrillar form of α-synuclein-induced rat model of Parkinson’s disease. ACS Chem Neurosci 12:2643–2660
Zhu Y, Liu F, Zou X, Torbey M (2015) Comparison of unbiased estimation of neuronal number in the rat hippocampus with different staining methods. J Neurosci Methods 254:73–79
Kobelt P, Tebbe JJ, Tjandra I et al (2004) Two immunocytochemical protocolDisease is Augmenteds for immunofluorescent detection of c-Fos positive neurons in the rat brain. Brain Res Protoc 13:45–52
Yun S-M, Cho S-J, Jo C, et al (2020) Elevation of plasma soluble amyloid precursor protein beta in Alzheimer’s disease. Arch Gerontol Geriatr 87:103995
Gong Q, Hu Z, Zhang F et al (2016) Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice. Hepatology 64:425–438
Acknowledgements
Authors are thankful to Birla Institute of Technology and Science-Pilani (BITS-Pilani), Pilani Campus, Rajasthan, India; Taipei Medical University (TMU), Taipei, Taiwan; and Indian Council for Medical Research (ICMR), New Delhi, India, for their support for this study.
Author information
Authors and Affiliations
Contributions
Violina Kakoty, Rajeev Taliyan, Sunil Kumar Dubey, Chih HaoYang, designed the study protocol, Violina Kakoty and Sarathlal KC performed the experiments, analysed, interpreted the data and wrote the manuscript, Violina Kakoty and Shobha Kumari processed the rat brain sections for histochemical analysis and captured the images. Violina Kakoty and Chih Hao Yang analysed the western blot, histochemical and immunofluorescence results, Rajeev Taliyan proof read the entire manuscript and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval
This study was performed in line with the principles of the Institutional Animal ethics committee, BITS-Pilani, Pilani campus, Rajasthan, India (IAEC/RES/30/07).
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kakoty, V., C, S.K., Yang, CH. et al. Neuroprotective Effect of Lentivirus-Mediated FGF21 Gene Delivery in Experimental Alzheimer’s Disease is Augmented when Concerted with Rapamycin. Mol Neurobiol 59, 2659–2677 (2022). https://doi.org/10.1007/s12035-022-02741-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-022-02741-6